Invest Like Steven Cohen: Amazon.com, Inc. (AMZN), Facebook Inc. (FB), Nike Inc. (NKE)

Steven Cohen is one of the most successful hedge fund managers in the United States. His phenomenal success has earned him titles such as the “Hedge Fund King” and the “Prince of Wall Street.” He manages a fund called Point72 Asset Management with his portfolio valued at $14.44 billion. In the last year, Cohen’s holdings have … Read more

Facebook (FB) Stock: What You Need To Know!

Facebook Inc (NASDAQ: FB) Although Facebook has been caught up in market’s volatility with its shares down about 5% in last month the social media networking service’s long-term success is, still, unrivaled among tech companies of this size. Mostly because the company’s stock witnessed substantial gains this year. The information technology sector dragged on the S&P … Read more

Facebook (FB) Stock Declines On Concerns Over Internet.org

Facebook Inc (NASDAQ: FB) Facebook is the world’s largest social network. With billions of active users, great advertising campaigns and more, the stock has grown exponentially since its IPO. One of the bigger picture efforts of Facebook has been to connect the world to the internet; doing so through Internet.org. However, there are some big … Read more

Facebook Inc and Amazon.com, Inc: Top-Ranked Analyst Bullish

Top-ranked Cantor Fitzgerald analyst Youssef Squali, who rates internet and media stocks, recently shared his views onFacebook Inc (NASDAQ:FB) and Amazon.com, Inc. (NASDAQ:AMZN). Facebook, Inc. Last week, Facebook announced its plans to partner with Moat, an advertising analytics company, so it can independently measure the performance of its video ads. This means advertisers won’t have … Read more

Today In The Market | EnteroMedics (ETRM), Ariad Pharmaceuticals (ARIA), Baxalta (BXLT), Twitter (TWTR), Facebook (FB)

EnteroMedics Study Data Excites Investors EnteroMedics Inc (NASDAQ: ETRM) EnteroMedics is having a great day in the market today as investors are focused on the an analyses of the company’s ReCharge Study. The analyses demonstrated Excess Weight Loss of 34% and improvement in obesity-related risk factors associated with vBloc. While the data hit the media … Read more